Eurepa-V 0.5/0.3 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Repaglinide (0.5mg) + Voglibose (0.3mg)
Overview Eurepa-V 0.5/0.3 Tablet
Diabex Duo 0.5/0.3mg tablets combine two medications to manage type 2 diabetes. This dual-action formulation helps regulate post-prandial blood glucose. It's prescribed when dietary changes and other similar treatments fail to adequately control elevated blood sugar. Diabex Duo should be taken immediately following meals; dosage is determined by your physician. Discontinuing treatment without medical consultation may lead to dangerously high blood sugar, potentially causing severe complications such as kidney disease and vision impairment. If a dose is missed, avoid taking it between meals; simply take it with your next meal as usual. Never double the dose. This medication is part of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management, as advised by your doctor. Common, generally transient side effects include gas, diarrhea, abdominal discomfort, hypoglycemia (low blood sugar), and skin reactions. Persistent or worsening side effects require medical attention. Regular blood glucose monitoring is crucial while using this medication. Before starting treatment, disclose any kidney, liver, or urinary tract issues, diuretic use, or pregnancy/breastfeeding status to your doctor. Limit alcohol consumption to minimize the risk of adverse reactions.
Uses of Eurepa-V 0.5/0.3 Tablet
Managing Type 2 Diabetes
Major Benefits of Eurepa-V 0.5/0.3 Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Eurepa-V 0.5/0.3 Tablet with a meal.
Common Side effects of Eurepa-V 0.5/0.3 Tablet:
- Hypoglycemia (low blood glucose level)
- Abdominal pain
- Diarrhea
- Flatulence
- Headache
How to use Eurepa-V 0.5/0.3 Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Eurepa-V 0.5/0.3 Tablet with a meal.
How Eurepa-V 0.5/0.3 Tablet works:
The combined antidiabetic medication Eurepa-V 0.5/0.3 Tablet contains two active pharmaceutical ingredients.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Eurepa-V 0.5/0.3 Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Eurepa-V 0.5/0.3 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing this medication. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Eurepa-V 0.5/0.3 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with severe renal impairment should exercise caution when using Eurepa-V 0.5/0.3 Tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Eurepa-V 0.5/0.3 Tablet. Dosage modification for Eurepa-V 0.5/0.3 Tablet may be necessary. Physician consultation is advised.
What if you forget to take Eurepa-V 0.5/0.3 Tablet :
Should you forget a Eurepa-V 0.5/0.3 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Eurepa-V 0.5/0.3 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently